ResearcherNebraska Medical CenterNo recent work listed
Goutam Mondal
Matched on ORCID iD 0000-0001-6067-8030; OpenAlex author ID A5058281476. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2015: 2 papers · 2016: 1 paper · 2017: 3 papers · 2018: 1 paper
Papers 7
- Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis. First author DOI 10.1007/s11095-017-2303-3↗
- Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. First author DOI 10.1016/j.canlet.2017.05.007↗
- EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.7b00355↗
- Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer. Co-author DOI 10.1038/s41598-017-01942-7↗
- EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer. Co-author DOI 10.1021/acs.biomac.5b01419↗
- Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer. First author DOI 10.1021/mp500847s↗
- Impact of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir in patients with pancreatic cancer. Co-author DOI 10.1111/bcp.12620↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ram I. Mahato · 7 shared papers, 2015–2018 · strength 0.59
- Paper Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Ca… DOI 10.1007/s11095-017-2303-3↗
- Paper EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancrea… DOI 10.1021/acs.molpharmaceut.7b00355↗
- Paper Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. DOI 10.1016/j.canlet.2017.05.007↗
- Virender Kumar · 4 shared papers, 2015–2017 · strength 0.30
- Paper Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. DOI 10.1016/j.canlet.2017.05.007↗
- Paper EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer. DOI 10.1021/acs.biomac.5b01419↗
- Paper Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer. DOI 10.1038/s41598-017-01942-7↗
- Amit Chaudhary · 3 shared papers, 2017 · strength 0.26
- Paper EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancrea… DOI 10.1021/acs.molpharmaceut.7b00355↗
- Paper Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. DOI 10.1016/j.canlet.2017.05.007↗
- Paper Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer. DOI 10.1038/s41598-017-01942-7↗
- Saud Almawash · 2 shared papers, 2017–2018 · strength 0.24
- Paper Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Ca… DOI 10.1007/s11095-017-2303-3↗
- Paper EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancrea… DOI 10.1021/acs.molpharmaceut.7b00355↗
- Krishna Kattel · 2 shared papers, 2015–2017 · strength 0.15
- Pankaj Kumar Singh · 1 shared paper, 2016 · strength 0.08
- Surendra Kumar Shukla · 1 shared paper, 2016 · strength 0.08
- Vinod Kumar · 1 shared paper, 2017 · strength 0.07
- Jean L. Grem · 1 shared paper, 2015 · strength 0.06
- Surinder K. Batra · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.